Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 13/20 | 0.61 |
| ▸ | ELANE | P08246 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | CTSK | P43235 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 3/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4445986 | 1.00 | CMA1 (0.61) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL2162326 | 1.00 | CMA1 (0.61) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL8168155 | 1.00 | CMA1 (0.61) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL17378396 | 1.00 | CMA1 (0.61) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL6740347 | 0.92 | CMA1 (0.53) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL29787416 | 0.91 | CMA1 (0.53) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL13258959 | 0.90 | CMA1 (0.51) | CMA1ELANECTSLCTSBCTSK | |
| SCHEMBL28603270 | 0.89 | CMA1 (0.51) | CMA1ELANEACEREN | |
| SCHEMBL28603273 | 0.89 | CMA1 (0.51) | CMA1ELANEACEREN | |
| SCHEMBL28603275 | 0.89 | CMA1 (0.51) | CMA1ELANEACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265480-A1 | METHOD FOR DETECTION OF MICROORGANISMS | NEMIS TECH AG (CH) | 2023-08-24 | — | — | US | claimed |
| US-11649475-B2 | Dioxetane compounds and their use for the detection of microorganisms | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-05-16 | — | — | US | claimed |
| US-20260027131-A1 | PRODRUGS, PRODRUG COMPOSITIONS AND RELATED METHODS | PRAESIDIA BIOTHERAPEUTICS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12466850-B2 | Method for producing peptide compound | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-11 | — | — | US | disclosed |
| US-12415819-B2 | Cu- and Ni-catalyzed decarboxylative borylation reactions | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-09-16 | — | — | US | disclosed |
| CN-120202010-A | Ligand-oligonucleotide conjugates and linkers for use therewith | 上海京新生物医药有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-12240871-B2 | Method for producing peptide compound | NISSAN CHEMICAL CORPORATION (JP) | 2025-03-04 | — | — | US | disclosed |
| CN-115210244-B | Elastase inhibitor prodrug and application thereof | 苏州爱科百发生物医药技术有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118772216-A | 5-Fluorouracil nucleoside phosphoramidate compound and application thereof | 北京深蓝泰医药科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| EP-4023661-B1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024083220-A1 | LIGAND-OLIGONUCLEOTIDE CONJUGATE AND LINKER FOR CONJUGATE | 上海京新生物医药有限公司 | 2024-04-25 | — | — | WO | disclosed |
| US-6008196-A | AN ENZYME INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | HOECHST MARION ROUSSEL, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0763055-B1 | PERFLUOROALKYL KETONE INHIBITORS OF ELASTASE AND PROCESSES FOR MAKING THE SAME | MERRELL PHARMA INC (US) | 1999-11-03 | — | — | EP | disclosed |
| US-5714470-A | PENTAFLUORO ALKYL TERMINATED PEPTIDE DERIVATIVES; TREATMENT OF INFLAMMATORY DISEASES, EMPHYSEMA AND CHRONIC BRONCHITIS | MERRELL PHARMACEUTICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| US-4971993-A | HYPOTENSIVE DIPEPTIDES DERIVATIVES | AJINOMOTO CO., INC. (JP) | 1990-11-20 | — | — | US | disclosed |
| US-4691007-A | HUMAN LEUKOCYTE ELASTASE INHIBITORS | ICI AMERICAS INC. (US) | 1987-09-01 | — | — | US | disclosed |
| US-4684660-A | Mercaptoacyldepeptides | E. R. SQUIBB & SONS, INC. (US) | 1987-08-04 | — | — | US | disclosed |
| EP-0190852-A2 | Dipeptide derivatives and antihypertensive drugs containing them | AJINOMOTO CO., INC. (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4596789-A | Pharmaceuticals | ICI AMERICAS INC. (US) | 1986-06-24 | — | — | US | disclosed |
| EP-0124317-A2 | Proline derivatives | ICI AMERICAS INC. (US) | 1984-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027131-A1 | PRODRUGS, PRODRUG COMPOSITIONS AND RELATED METHODS | DNPEP, SLC7A1, SLC6A7 | CMA1 634/4885ELANE 3218/4885CTSL 92/4885 |
| US-11649475-B2 | Dioxetane compounds and their use for the detection of microorganisms | DAXX, LITAF, EDF1 | CMA1 3341/4885ELANE 1504/4885CTSL 4469/4885 |
| US-12466850-B2 | Method for producing peptide compound | VIP, NGLY1, NPR1 | CMA1 218/4885ELANE 2125/4885CTSL 450/4885 |
| US-12415819-B2 | Cu- and Ni-catalyzed decarboxylative borylation reactions | PCSK9, PCSK7, PCSK6 | CMA1 14/4885ELANE 530/4885CTSL 97/4885 |
| US-12240871-B2 | Method for producing peptide compound | NGLY1, NPPA, NPEPPS | CMA1 550/4885ELANE 815/4885CTSL 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.